[HTML][HTML] Diagnostic, prognostic, and recurrence monitoring value of plasma CYFRA21-1 and NSE levels in patients with esophageal squamous cell carcinoma
M Ju, X Ge, X Di, Y Zhang, L Liang, Y Shi - Frontiers in Oncology, 2022 - frontiersin.org
This study was aimed to evaluate the clinical values of single markers and combination in
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …
[HTML][HTML] Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
M Ju, X Ge, X Di, Y Zhang, L Liang, Y Shi - Frontiers in Oncology, 2021 - ncbi.nlm.nih.gov
This study was aimed to evaluate the clinical values of single markers and combination in
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …
Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
M Ju, X Ge, X Di, Y Zhang, L Liang… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
This study was aimed to evaluate the clinical values of single markers and combination in
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …
Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.
M Ju, X Ge, X Di, Y Zhang, L Liang, Y Shi - Frontiers in Oncology, 2022 - europepmc.org
Methods Totally 50 patients with I-IVa stage ESCC, 50 healthy controls and 11 patients with
recurrent esophageal cancer after comprehensive treatment were enrolled. Serum …
recurrent esophageal cancer after comprehensive treatment were enrolled. Serum …
Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.
M Ju, X Ge, X Di, Y Zhang, L Liang, Y Shi - Frontiers in Oncology, 2022 - europepmc.org
Methods Totally 50 patients with I-IVa stage ESCC, 50 healthy controls and 11 patients with
recurrent esophageal cancer after comprehensive treatment were enrolled. Serum …
recurrent esophageal cancer after comprehensive treatment were enrolled. Serum …